60
Participants
Start Date
June 30, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Almonertinib
"Almonertinib, dosing regimen: 110mg/day orally, once daily in a 28-day cycle, continuously.~Lastet, dosing regimen: 50 mg/day orally, every 28 days in a cycle, two weeks of continuous oral administration, two weeks off."
Zhongshan hospital, Shanghai
The First Affiliated Hospital of Xiamen University, Xiamen
Shanghai Zhongshan Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER
Shanghai Pulmonary Hospital, Shanghai, China
OTHER